226 - 250 of 7877 Results
Title
Year
- Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders2024OPENTitle: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disordersJournal Name: Bioengineering & Translational MedicinePublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/btm2.10665Citation Count: 0
- [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease2024OPENTitle: [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s DiseaseJournal Name: Neurology InternationalPublisher: MDPI AGVol: 16Issue #: 2Start Page: 419End Page: 431Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/neurolint16020031Citation Count: 3
- Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives2024OPENTitle: Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to RelativesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 786End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14043Citation Count: 0
- A RAB7A phosphoswitch coordinates Rubicon Homology protein regulation of Parkin-dependent mitophagy2024OPENTitle: A RAB7A phosphoswitch coordinates Rubicon Homology protein regulation of Parkin-dependent mitophagyJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202309015Best OA location URL: https://rupress.org/jcb/article-pdf/223/7/e202309015/1928200/jcb_202309015.pdfCitation Count: 4
- An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders2024OPENTitle: An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disordersJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00723-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-024-00723-xCitation Count: 0
- Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRI2024OPENTitle: Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRIJournal Name: Frontiers in RadiologyPublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fradi.2024.1283392Citation Count: 0
-
OPENTitle: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06534-8Citation Count: 1
-
OPENTitle: Orthogonal analysis of mitochondrial function in Parkinson’s disease patientsJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06617-6Best OA location URL: https://www.nature.com/articles/s41419-024-06617-6.pdfCitation Count: 0
-
OPENTitle: RedOx regulation of LRRK2 kinase activity by active site cysteinesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00683-5Citation Count: 2
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease2024OPENTitle: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1162End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26923Citation Count: 1
-
OPENTitle: An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 98Issue #: 3Start Page: 1053End Page: 1067Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-231075Citation Count: 2
- DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease2024OPENTitle: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s diseaseJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 46Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11357-024-01116-0Citation Count: 1
-
OPENTitle: Identification and structural characterization of small molecule inhibitors of PINK1Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-58285-3Citation Count: 0
-
OPENTitle: Real-World Experiences of Parkinson's Disease OFF Time and Role of DemographicsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 11Issue #: 1Start Page: 8End Page: 17Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.17294/2330-0698.2057Citation Count: 0
-
OPENTitle: Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 16Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/dad2.12589Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dad2.12589Citation Count: 0
- Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s disease2024OPENTitle: Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 56Issue #: 4Start Page: 935End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s12276-024-01202-5Citation Count: 0
- Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains2024OPENTitle: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domainsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12461Citation Count: 3
-
OPENTitle: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-02886-yCitation Count: 10
- RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction2024OPENTitle: RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunctionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 196Issue #:Start Page: 106514End Page: 106514Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106514Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106514Citation Count: 1
- The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystonia2024OPENTitle: The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystoniaJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 134Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci177833Citation Count: 1
-
OPENTitle: Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00685-3Best OA location URL: https://www.nature.com/articles/s41531-024-00685-3.pdfCitation Count: 1
-
OPENTitle: Genotype–phenotype correlation in PRKN-associated Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00677-3Citation Count: 7
-
OPENTitle: Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-46832-5Citation Count: 12
-
OPENTitle: Development and characterization of a non-human primate model of disseminated synucleinopathyJournal Name: Frontiers in NeuroanatomyPublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnana.2024.1355940Citation Count: 0
- Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease2024RESTRICTEDTitle: Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's diseaseJournal Name:Publisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1101/2024.03.22.586364Citation Count: